If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...

Pinterest stock jumped late Thursday after the social media company reported fourth quarter results with a strong sales forecast.

All of a sudden, Amgen stock is up 15% since late December to around $299. Its rise helped push up the healthcare sector up ...

Pfizer's Q4 2024 earnings beat expectations, but concerns over 2025 guidance and patent expirations led to stock decline. See ...

U.S. health experts anticipate a smaller wave of COVID-19 cases this winter, potentially impacting Pfizer's non-COVID ...

Nasdaq 100, S&P 500, Dow Jones Industrial Average, Intel Corporation. Read Investing.com (Jesse Cohen)'s latest article on ...

“Difficult to answer because as we learned last time, I mean, Donald Trump is not a predictable president, great for cable ...

Analysts on Wall Street project that Pfizer (PFE) will announce quarterly earnings of $0.48 per share in its forthcoming report, representing an increase of 380% year over year. Revenues are projected ...

Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price traded down 0.6% during trading on Tuesday after Citigroup lowered their price target on the stock from $30.00 to $29.00. Citigroup currently has ...

Pfizer (PFE) closed the latest trading day at $26.75, indicating a -0.41% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.92%. At the same ...